A Subset of Type I Conventional Dendritic Cells Controls Cutaneous Bacterial Infections through VEGFα-Mediated Recruitment of Neutrophils.


Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
16 04 2019
Historique:
received: 09 03 2018
revised: 14 11 2018
accepted: 27 02 2019
pubmed: 31 3 2019
medline: 17 9 2019
entrez: 31 3 2019
Statut: ppublish

Résumé

Skin conventional dendritic cells (cDCs) exist as two distinct subsets, cDC1s and cDC2s, which maintain the balance of immunity to pathogens and tolerance to self and microbiota. Here, we examined the roles of dermal cDC1s and cDC2s during bacterial infection, notably Propionibacterium acnes (P. acnes). cDC1s, but not cDC2s, regulated the magnitude of the immune response to P. acnes in the murine dermis by controlling neutrophil recruitment to the inflamed site and survival and function therein. Single-cell mRNA sequencing revealed that this regulation relied on secretion of the cytokine vascular endothelial growth factor α (VEGF-α) by a minor subset of activated EpCAM

Identifiants

pubmed: 30926233
pii: S1074-7613(19)30091-3
doi: 10.1016/j.immuni.2019.03.001
pii:
doi:

Substances chimiques

RNA, Messenger 0
VEGFA protein, human 0
Vascular Endothelial Growth Factor A 0
vascular endothelial growth factor A, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

1069-1083.e8

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Baptiste Janela (B)

Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), 8A Biomedical Grove, Biopolis, Singapore 138648, Singapore; Skin Research Institute of Singapore (SRIS), Agency for Science, Technology and Research (A(∗)STAR), 11 Mandalay Rd., Singapore 308232, Singapore.

Amit A Patel (AA)

Division of Medicine, University College London, University of London, London WC1E 6BT, England, UK.

Mai Chan Lau (MC)

Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), 8A Biomedical Grove, Biopolis, Singapore 138648, Singapore.

Chi Ching Goh (CC)

Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), 8A Biomedical Grove, Biopolis, Singapore 138648, Singapore.

Rasha Msallam (R)

Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), 8A Biomedical Grove, Biopolis, Singapore 138648, Singapore.

Wan Ting Kong (WT)

Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), 8A Biomedical Grove, Biopolis, Singapore 138648, Singapore.

Michael Fehlings (M)

Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), 8A Biomedical Grove, Biopolis, Singapore 138648, Singapore.

Sandra Hubert (S)

Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), 8A Biomedical Grove, Biopolis, Singapore 138648, Singapore.

Josephine Lum (J)

Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), 8A Biomedical Grove, Biopolis, Singapore 138648, Singapore.

Yannick Simoni (Y)

Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), 8A Biomedical Grove, Biopolis, Singapore 138648, Singapore.

Benoit Malleret (B)

Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), 8A Biomedical Grove, Biopolis, Singapore 138648, Singapore; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.

Francesca Zolezzi (F)

Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), 8A Biomedical Grove, Biopolis, Singapore 138648, Singapore; Nestlé Skin Health R&D/GALDERMA, La Tour-de-Peilz 1814, Switzerland.

Jinmiao Chen (J)

Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), 8A Biomedical Grove, Biopolis, Singapore 138648, Singapore.

Michael Poidinger (M)

Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), 8A Biomedical Grove, Biopolis, Singapore 138648, Singapore.

Ansuman T Satpathy (AT)

Department of Pathology and Immunology, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110, USA.

Carlos Briseno (C)

Department of Pathology and Immunology, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110, USA.

Christian Wohn (C)

Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM, CNRS UMR, Marseille 13288, France.

Bernard Malissen (B)

Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM, CNRS UMR, Marseille 13288, France; Centre d'Immunophénomique, Aix Marseille Université, INSERM, CNRS, Marseille 13288, France.

Kenneth M Murphy (KM)

Department of Pathology and Immunology, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110, USA.

Alexander A Maini (AA)

Division of Medicine, University College London, University of London, London WC1E 6BT, England, UK.

Leen Vanhoutte (L)

Transgenic Mouse Core Facility, VIB-UGnet Center for Inflammation Research, Technologiepark 71, Ghent 9052, Belgium; Department of Biomedical Molecular Biology, Ghent University, Technologiepark 71, Ghent 9052, Belgium.

Martin Guilliams (M)

Department of Biomedical Molecular Biology, Ghent University, Technologiepark 71, Ghent 9052, Belgium; Laboratory of Myeloid Cell Ontogeny and Functional Specialization, VIB-UGnet Center for Inflammation Research, Technologiepark 71, Ghent 9052, Belgium.

Emmanuel Vial (E)

Nestlé Skin Health R&D/GALDERMA, La Tour-de-Peilz 1814, Switzerland.

Laurent Hennequin (L)

Nestlé Skin Health R&D/GALDERMA, La Tour-de-Peilz 1814, Switzerland.

Evan Newell (E)

Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), 8A Biomedical Grove, Biopolis, Singapore 138648, Singapore.

Lai Guan Ng (LG)

Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), 8A Biomedical Grove, Biopolis, Singapore 138648, Singapore.

Philippe Musette (P)

Department of Dermatology, Avicenne Hospital and INSERM U1125, Bobigny 93000, France.

Simon Yona (S)

Division of Medicine, University College London, University of London, London WC1E 6BT, England, UK.

Feriel Hacini-Rachinel (F)

Nestlé Skin Health R&D/GALDERMA, La Tour-de-Peilz 1814, Switzerland.

Florent Ginhoux (F)

Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), 8A Biomedical Grove, Biopolis, Singapore 138648, Singapore; Skin Research Institute of Singapore (SRIS), Agency for Science, Technology and Research (A(∗)STAR), 11 Mandalay Rd., Singapore 308232, Singapore. Electronic address: florent_ginhoux@immunol.a-star.edu.sg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH